Management of Metastatic Non-Small Cell Lung Cancer without an Actionable Mutation
Oncology Today with Dr Neil Love
00:00
A Case Study on Data-Potomab-Dirac-Stikan
The patient's now about six months into treatment on data-potomab-dirac-Stikan. She has had a partial response, is doing extremely well clinically. But if you had to ask me, I think it will be someone who goes out 10 years plus with metastatic disease,. which would have seemed unthinkable when I started in practice.
Transcript
Play full episode
